This issue features the winner of the 2007 H.J.C. Swan Memorial Prize for Medical Writing, established by former Editor-in-Chief Joe Alpert to foster medical writing skills among trainees and early posttraining biomedical scientists who work in the field of cardiovascular diseases. Dr. Swan's name, added to the contest 2 years ago with permission from his widow, commemorates the fact that, in addition to his own towering contributions to medical knowledge through research, H.J.C. Swan was an indefatigable proponent of involvement of trainees and young investigators in scientific inquiry, investigation and, subsequently, medical writing. The winner is selected by a panel of 7, now chaired by Ira Gelb, MD, Associate Editor of Cardiology and former Senior Associate Editor of the Journal of the American College of Cardiology and, before that, of the American Journal of Cardiology . This year, the winning submission is a truly comprehensive review of the pathophysiology, evaluation and management of ischemic mitral regurgitation. The topic is quite timely. With the aging of our population, valve diseases, themselves largely diseases of aging, have become progressively more prevalent. Indeed, current estimates suggest some echocardiographically identifiable functional valve abnormality is present in more than half of persons older than 70 years. One of the reasons for this relatively high prevalence is the continually improving survival of patients afflicted with other medical problems that, in an earlier era, would have been fatal before age 70. Certainly, one of the most successful survival stories is that of patients with coronary artery disease and, particularly, of those who suffer myocardial infarction, the
